Dissemination and exploitation

Main objectives:

  • To implement a comprehensive dissemination strategy, taking into consideration the information needs of various stakeholder groups (clinical, managerial, patient groups, commercial).
  • To analyse contextual factors relevant for the translation of the novel techniques and tools into routine practice
  • To develop plans for the commercial exploitation of the research findings


We develop a communication and dissemination strategy adjusted to the different stakeholder groups. The design of the strategy is informed by force field analysis and include traditional and social media channels. We conduct systematic search of scientific and grey literature to identify and analyse multiple policy and regulatory frameworks relevant to the introduction of self-management/decision-making tools. Our analyses focus on gauging strengths, weaknesses, opportunities, and threats for the translation of the COMPAR-EU tools into routine clinical practice. We also analyse and synthesise contextual and implementation factors that influence the uptake and effectiveness of decision-making tools in different health system contexts (Germany, France, Spain, Greece, and the Netherlands). We host workshops with industry, pharma, and SMEs to deepen the understanding of how the decision-making tools could be embedded in the value chain and to assess commercial issues surrounding market exploitation, such as competition and procurement procedures. We conduct case studies in participating countries to inform the development of business cases. Business plans address national, regional and local health systems and provide a clear case for investment, specifying the prerequisites for implementation.

Leading partner: OptiMedis AG, Germany

Other partners involved:

  • Fundación Avedis Donabedian (FAD), Spain
  • European Patients’ Forum (EPF), Belgium
  • Institute for Medical Technology Assessment (iMTA), The Netherlands
  • Netherlands Institute for Health Services Research (Nivel), The Netherlands
  • Fundació Privada Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau (IR-HSCSP), Spain
  • University of Ioannina (UOI), Greece